Indeed, rather than exerting a direct cytotoxic effect on breast cancer cells, cabazitaxel appears to induce an NF-κB-mediated macrophage’s polarization toward a M1 state stimulating the programmed cell removal (PrCR) macrophage activity [202]. Here, NFKB1 is linked to breast cancer.